BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17875527)

  • 1. Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation.
    Uchiumi H; Matsushima T; Yamane A; Doki N; Irisawa H; Saitoh T; Sakura T; Jimbo T; Handa H; Tsukamoto N; Karasawa M; Miyawaki S; Murakami H; Nojima Y
    Int J Hematol; 2007 Aug; 86(2):137-42. PubMed ID: 17875527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study.
    Guo Z; Chen X; Tan Y; Xu Z; Xu L
    Blood Cells Mol Dis; 2020 Mar; 81():102393. PubMed ID: 31918382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemias resembling acute promyelocytic leukemia, microgranular variant.
    Nagendra S; Meyerson H; Skallerud G; Rosenthal N
    Am J Clin Pathol; 2002 Apr; 117(4):651-7. PubMed ID: 11939742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of acute myeloid leukemia without HLA-DR expression.
    Moon H; Lee S; Huh J; Chung WS
    Korean J Lab Med; 2007 Oct; 27(5):313-7. PubMed ID: 18094594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.
    Yokoyama H; Takahashi N; Katsuoka Y; Inomata M; Ito T; Meguro K; Kameoka Y; Tsumanuma R; Murai K; Noji H; Ishizawa K; Ito S; Onishi Y; Harigae H;
    Int J Hematol; 2017 May; 105(5):606-613. PubMed ID: 28176226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
    Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
    Shahmarvand N; Oak JS; Cascio MJ; Alcasid M; Goodman E; Medeiros BC; Arber DA; Zehnder JL; Ohgami RS
    Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR antigen-negative acute myeloid leukemia.
    Wetzler M; McElwain BK; Stewart CC; Blumenson L; Mortazavi A; Ford LA; Slack JL; Barcos M; Ferrone S; Baer MR
    Leukemia; 2003 Apr; 17(4):707-15. PubMed ID: 12682628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Disseminated Intravascular Coagulation in Acute Leukemias.
    Ten Cate H; Leader A
    Hamostaseologie; 2021 Apr; 41(2):120-126. PubMed ID: 33860520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
    Huang YT; Liu XF; Fu RF; Chen YF; Liu W; Xue F; Zhang L; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):480-484. PubMed ID: 30032565
    [No Abstract]   [Full Text] [Related]  

  • 13. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cardiovascular complications of disseminated intravascular coagulation in acute myeloid leukemia.
    Araji G; Mustafa A; Niazi M; Wei C; Sharma R; Abu-Baker S; Khattar G; El-Sayegh S; Odaimi M
    Thromb Res; 2024 Jul; 239():109042. PubMed ID: 38796899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of acute leukemia with disseminated intravascular coagulation in adults. Analysis of 14 cases].
    Zuazu I; Canals C; Sempere A; Martín S; Brunet S; Puig J; Fontcuberta J; Grau E
    Med Clin (Barc); 1989 Oct; 93(12):441-4. PubMed ID: 2607808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
    Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated intravascular coagulation in acute leukaemias at first diagnosis.
    Nur S; Anwar M; Saleem M; Ahmad PA
    Eur J Haematol; 1995 Aug; 55(2):78-82. PubMed ID: 7628593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation.
    Lee HJ; Park HJ; Kim HW; Park SG
    Blood Res; 2013 Dec; 48(4):250-3. PubMed ID: 24466548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
    Iriyama N; Asou N; Miyazaki Y; Yamaguchi S; Sato S; Sakura T; Maeda T; Handa H; Takahashi M; Ohtake S; Hatta Y; Sakamaki H; Honda S; Taki T; Taniwaki M; Miyawaki S; Ohnishi K; Kobayashi Y; Naoe T
    Ann Hematol; 2014 Jun; 93(6):957-63. PubMed ID: 24441947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.